| |
| |
|
| Insider
Information: |
Milligan John F |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,574,306 |
|
|
Indirect Shares
|
211,755 |
|
|
| Direct
Value |
$105,494,245 |
|
|
|
Indirect Value
|
$7,488,703 |
|
|
| Total
Shares |
1,786,061 |
|
|
| Total
Value |
$112,982,948 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
President and CEO, Dir... |
2018-11-27 |
1,574,306 |
2012-01-06 |
111,755 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-15 |
0 |
2020-12-15 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
159 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
COO |
• – – |
2007-12-03 |
4 |
OE |
$8.58 |
$514,878 |
D/D |
60,000 |
267,393 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO |
• – – |
2007-12-03 |
4 |
S |
$45.55 |
$2,766,845 |
D/D |
(60,000) |
207,393 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO |
• – – |
2007-12-21 |
4 |
OE |
$3.70 |
$24,071 |
D/D |
6,500 |
213,893 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2007-06-04 |
4 |
OE |
$9.81 |
$294,300 |
D/D |
30,000 |
133,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2007-06-04 |
4 |
AS |
$82.35 |
$2,150,678 |
D/D |
(26,100) |
107,201 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2007-06-04 |
4 |
AS |
$82.64 |
$322,935 |
D/D |
(3,900) |
103,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2007-09-04 |
4 |
OE |
$4.91 |
$319,005 |
D/D |
60,000 |
267,393 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2007-09-04 |
4 |
AS |
$36.46 |
$2,203,575 |
D/D |
(60,000) |
207,393 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2008-03-03 |
4 |
S |
$47.40 |
$2,880,670 |
D/D |
(60,000) |
213,893 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2008-03-03 |
4 |
OE |
$8.58 |
$514,878 |
D/D |
60,000 |
273,893 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
227,893 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2008-03-17 |
4 |
D |
$47.55 |
$304,510 |
D/D |
(6,404) |
221,489 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2020-12-15 |
4 |
B |
$23.00 |
$2,300,000 |
I/I |
100,000 |
100,000 |
2.1 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2003-06-30 |
4 |
A |
$29.66 |
$19,188 |
D/D |
647 |
43,365 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2003-08-07 |
4 |
OE |
$5.72 |
$144,157 |
D/D |
11,000 |
49,656 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2003-08-07 |
4 |
S |
$63.21 |
$695,930 |
D/D |
(11,000) |
44,012 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-02-03 |
4 |
S |
$56.89 |
$398,277 |
D/D |
(7,000) |
44,081 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-02-03 |
4 |
OE |
$14.81 |
$103,688 |
D/D |
7,000 |
51,081 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-05-03 |
4 |
OE |
$14.81 |
$118,500 |
D/D |
8,000 |
52,081 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-05-03 |
4 |
S |
$60.11 |
$481,812 |
D/D |
(8,000) |
44,081 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-08-04 |
4 |
OE |
$14.16 |
$118,356 |
D/D |
8,000 |
51,861 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-08-04 |
4 |
S |
$63.50 |
$508,000 |
D/D |
(8,000) |
44,081 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-10-27 |
4 |
OE |
$7.41 |
$162,939 |
D/D |
22,000 |
111,596 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-10-27 |
4 |
S |
$34.50 |
$759,005 |
D/D |
(22,000) |
89,596 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-12-28 |
4 |
OE |
$7.30 |
$29,188 |
D/D |
4,000 |
92,302 |
|
- |
|
159 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
